ArticleCellular oncology (Dordrecht, Netherlands)2024

DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma.

Rui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.